Surveillance of Fungal Infections During Construction Activity - Tabular View

Tracking Information

First Received Date ^ICMJE

May 14, 2007

Last Updated Date

June 4, 2008

Start Date ^ICMJE

May 2006

Primary Completion Date

Current Primary Outcome Measures ^ICMJE

Original Primary Outcome Measures ^ICMJE

Change History

Complete list of historical versions of study NCT00473252 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Original Secondary Outcome Measures ^ICMJE

Descriptive Information

Brief Title ^ICMJE

Surveillance of Fungal Infections During Construction Activity

Official Title ^ICMJE

Brief Summary

Fungal infections in immunocompromised patients occuring during construction activities in hospitals have repeatedly been reported.

However, the question of a causal relation between construction activities and infections has never been addressed systematically and prospectively.

To answer this question, we will monitor our immunosuppressed patients' health status, as well as fine dust and aspergillus spore contents in the air during a three year construction activity period in our hospital.

Detailed Description

Study Phase

Study Type ^ICMJE

Observational

Study Design ^ICMJE

Prospective

Condition ^ICMJE

Aspergillosis

Intervention ^ICMJE

Study Arms / Comparison Groups

Publications *

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Recruiting

Estimated Enrollment ^ICMJE

200

Estimated Completion Date

May 2009

Primary Completion Date

Eligibility Criteria ^ICMJE

Inclusion Criteria:

Kidney transplantation
Chronic hemodialysis treatment

Gender

Both

Ages

16 Years and older

Accepts Healthy Volunteers

Contacts ^ICMJE

Contact: Andreas Pasch, MD

0041 31 632 2198

andreas.pasch@insel.ch

Location Countries ^ICMJE

Switzerland

Administrative Information

NCT ID ^ICMJE

NCT00473252

Responsible Party

Study ID Numbers ^ICMJE

BE003

Study Sponsor ^ICMJE

University Hospital Inselspital, Berne

Collaborators ^ICMJE

Investigators ^ICMJE

Study Director:

Andreas Pasch, MD

University of Bern

Information Provided By

University Hospital Inselspital, Berne

Verification Date

June 2008

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP